Health · Washington, DC, US · United States of America · October 23, 2026

Brain-mapping magnetic therapy shows 68% PTSD remission in trial

Reported by 1 outlet · under-reported · first reported Oct 23, 7:02 AM ET

A newly FDA-cleared PTSD treatment using personalized brain mapping and magnetic stimulation reduced symptoms by 52% and achieved 68% remission in a clinical trial. Researchers said it could lead to more precise treatments for other mental health conditions.

Why it matters

It offers a new cleared option for a condition that often resists existing treatments.

Background

Post-traumatic stress disorder affects many veterans and survivors of violence. Transcranial magnetic stimulation is already used for depression.

The story so far

1. Oct 23Brain-mapping magnetic therapy shows 68% PTSD remission in trial
2. Oct 24Brain-stimulation PTSD treatment shows 68% remission

Follow the whole story →

Sources

• ScienceDaily ↗Oct 23, 7:02 AM ET

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Oct 23's stories